Search for: "Pharmaceutical Associates, Inc." Results 1061 - 1080 of 1,892
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jul 2009, 1:06 am
Levaquin, made by J&J subsidiary Ortho-McNeil Pharmaceutical Inc., was approved by the Food and Drug Administration in 1996, but in July 2008, the FDA warned that Levaquin, and other drugs in the fluoroquinolone class of antibiotics, put users at heightened risk of developing tendonitis and tendon ruptures. [read post]
3 Aug 2011, 3:31 am by Marie Louise
  Highlights this week included: US: CAFC confirms that isolated DNA may be patented: Association for Molecular Pathology v. [read post]
27 Mar 2014, 6:07 am by John Elwood
  Patent-infringement case Teva Pharmaceuticals USA, Inc. v. [read post]
8 Apr 2024, 9:47 am by Dennis Crouch
  Prior antipsychotic drugs have been associated with significant weight gain. [read post]
26 Apr 2007, 9:28 am
(b) does the first condition set out in Bristol-Myers Squibb as interpreted in Case C-379/97 Upjohn … [1999] ECR I-6927 and Boehringer Ingelheim and Others, namely that it must be shown that it is necessary to repackage the product in order that effective market access is not hindered, apply merely to the fact of reboxing (as held by the Court of Justice of the European Free Trade Association in Case E-3/02 Paranova v Merck) or does it also… [read post]
29 Jul 2020, 6:30 am by Rebecca Shafer, J.D.
Here are a few common assumptions and associated correct facts. [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
9 Jul 2018, 8:28 am by David Jensen
 "I need to make clear that the statement in the blog was written by me, and was not an official document of Stanford University, of Forty Seven, Inc, or from others from the discovery team. [read post]
1 Sep 2014, 7:04 am
Entries should be emailed to katcontest1@gmail.com by Monday 8 September 11 pm GMT. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]